Purchases and Sales Made in Q4 2022 in Ibere Pharmaceuticals Wt Exp (IBERWS)
This table provides information about the institutional ownership of Ibere Pharmaceuticals Wt Exp (IBERWS) during Q4 2022. The information is specifically focused on institutions that hold shares of IBERE PHARMACEUTICALS WT EXP.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 10, 2023
Q4 2022
|
Exos Tfp Holdings LLC
New York, NY |
BUY
|
- |
63.6K+ 921.74% |
N/A
|
70.5K
$0
|
|
|
Dec 06, 2023
Q4 2022
|
Tegean Capital Management, LLC
New York, NY |
BUY
|
- |
22.9KNew |
N/A
|
22.9K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Clear Street LLC
|
BUY
|
- |
8.76K+ 4.52% |
N/A
|
203K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ehp Funds Inc.
Toronto, Z4 |
BUY
|
- |
756+ 0.69% |
N/A
|
110K
$0
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Alpine Global Management, LLC
New York, NY |
SELL
|
- |
-50K- 81.14% |
N/A
|
11.6K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Magnetar Financial LLC
Evanston, IL |
SELL
|
- |
-182K- 52.62% |
N/A
|
164K
$0
|